Differences

This shows you the differences between two versions of the page.

--- covid-19_vaccines:lipid_nanoparticle [2022/11/24 19:43]
liam
+++ covid-19_vaccines:lipid_nanoparticle [2022/11/24 19:45] (current)
liam [Intellectual Property and Patents]
@@ Line 13: / Line 13: @@
 ===== Intellectual Property and Patents =====
-The ownership and licensure of the LNP technology underlying the [[:mRNA]] [[:COVID-19 vaccines]] is controversial.
+The ownership and licensure of the LNP technology underlying the [[:mRNA]] [[:COVID-19 vaccines]] is controversial. See the below graphic from //Patent network analysis of mRNA-based vaccine candidates for COVID-19//:((Gaviria, M., & Kilic, B. (2021). //A network analysis of COVID-19 mRNA vaccine patents.// Nature Biotechnology, 39(5), 546–548. https://doi.org/10.1038/s41587-021-00912-9))
 {{:covid-19_vaccines:41587_2021_912_fig1_html_copy.jpg?600 |}}